CRS+HIPEC in other gynecologic tumors:

16.7: CRS+HIPEC in peritoneal recurrence of Endometrial Cancer (surgery and previous RDT)

16.8: CRS+HIPEC in Peritoneal Recurrence of Primary Peritoneal Serous Carcinoma

16.9: CRS+HIPEC in peritoneal recurrence of Mucinous Endocervical Adenocarcinoma 

16.10: CRS+HIPEC in uterine sarcoma

16.11: CRS+HIPEC in Peritoneal Recurrence of Immature Teratoma (G2)